Year: 2022

Phase 2 clinical trial investigating KP1077 in patients with IH expected to initiate prior to year-end 2022 CELEBRATION, Fla., Nov. 18, 2022 (GLOBE NEWSWIRE) — KemPharm, Inc. (NasdaqGS: KMPH) (KemPharm, or the Company), a biotechnology company focused on the discovery, development and commercialization of novel treatments for rare central nervous system (CNS) and neurodegenerative diseases, lysosomal storage disorders and related treatment areas, today announced that the U.S. Food and Drug Administration (FDA) has granted the Orphan Drug Designation to serdexmethylphenidate (SDX), KemPharm’s proprietary prodrug of d-methylphenidate (d-MPH), for the treatment of idiopathic hypersomnia (IH), a rare neurological sleep disorder. SDX is the sole active pharmaceutical ingredient (API) in KP1077, KemPharm’s lead clinical candidate being...

Toronto, Nov. 18, 2022 (GLOBE NEWSWIRE) — Gulf & Pacific Equities Corp. (TSX-V: GUF) an established company focused on the acquisition, management and development of anchored shopping centres in Western Canada, reports a 3.5% decrease in revenues to $992,940 in the quarter ended September 30, 2022 from $1,029,139 at the same period last year. Details of the nine and three months financial results for fiscal 2022 and 2021 under International Financial Reporting Standards (IFRS) as summarized below are also available at www.sedar.com or the company’s website www.gpequities.com.  Nine Months Ended   Three Months Ended  (Unaudited)   (Unaudited)  Sept 30,   Sept 30,    2022     2021     2022   2021           Revenue $ 2,940,635   $ 2,901,882   $ 992,940 $ 1,029,139           Net Income (loss) before fair...

Sudhanshu Priyadarshi Wabash announces the appointment of Sudhanshu Priyadarshi to the company’s Board of Directors.LAFAYETTE, Ind., Nov. 18, 2022 (GLOBE NEWSWIRE) — Wabash (NYSE: WNC) and its Board of Directors are pleased to announce the appointment of Sudhanshu Priyadarshi to the company’s Board of Directors. Mr. Priyadarshi is a global finance and operations leader with extensive experience in the tech, logistics, e-commerce, retail, consumer packaged goods, and pharmaceutical industries in the U.S., Asia and Australia. He currently serves as Chief Financial Officer at Keurig Dr Pepper. Prior to joining Keurig Dr Pepper, he was Senior Vice President and Chief Financial Officer at Vista Outdoor, Inc., a leading global designer, manufacturer and marketer of consumer products in the outdoor sports and recreation markets. His...

Harvia Plc                                      Stock Exchange Release          18 November 2022 at 1:30 p.m. EETIn Harvia’s English stock exchange release regarding Tapio Pajuharju’s decision to leave Harvia, published on 17 November 2022 at 4:30 pm EET, there was an error regarding the date of the stock exchange release (11 November 2022). The correct date of the release is 17 November 2022. The date was correct in the Finnish version.For more information, please contact: Ari Vesterinen, CFO, tel. +358 40 5050 440Harvia is one of the leading companies operating in the sauna and spa market globally, as measured by revenue. Harvia’s brands and product portfolio are well known in the market, and the company’s comprehensive product portfolio strives to meet the needs of the international sauna and spa market of both private and professional...

The board of directors of IDEX Biometrics ASA has resolved to issue in total 246,167 ordinary shares at price NOK 0.15 per share to an employee who has exercised incentive subscription rights. The incentive subscription rights were issued under the company’s 2019 incentive subscription rights plan, which was approved by the annual general meeting on 9 May 2019. The employee has paid the subscription amount to the company. Following the issue, the company’s share capital will be NOK 167,637,217.35 divided into 1,117,581,449 shares each with a nominal value of NOK 0.15. Following the exercise, there are 82,865,280 incentive subscription rights outstanding. For further information contact:Marianne Bøe, Investor RelationsE-mail: marianne.boe@idexbiometrics.comTel: + 47 918 00186 About IDEX BiometricsIDEX Biometrics ASA (OSE: IDEX...

Digitalist Group Plc           Stock Exchange Release          18 November 2022 at 10:15 DIGITALIST GROUP PLC’S NEW SHARES REGISTERED IN THE TRADE REGISTER Digitalist Group Plc (“Company”) announced on October 28th, 2022 about a directed share issue of 31.400.000 shares to Turret Oy Ab (“Turret”). Turret has subscribed for the shares offered for subscription in the directed share issue in full and the Board of Directors of Digitalist Group has accepted Turret’s share subscription.The funds from the share issue are used to improve the Company’s liquidity and maintain and increase its solvency. The new shares subscribed have been registered into the Finnish Trade Register on November 18th, 2022. After the registration of the new shares, the company will have 682.422.746 shares in total. The new shares produce the shareholder rights...

Luxembourg – 18 November 2022 – Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) announced today the award of a contract to Subsea Integration Alliance1 to support the development of bp’s Cypre project, a gas development located offshore Trinidad and Tobago. Subsea7’s scope of the awarded Subsea Integration Alliance contract is substantial2. Subsea7’s scope covers the concept and design, engineering, procurement, construction and installation of a two-phase liquid natural gas tieback to the Juniper platform through dual flexible flowlines and a manifold gathering system, along with topside upgrades. Design, engineering, and project management will commence immediately at Subsea7’s offices in the USA, with offshore installation planned for 2024. Craig Broussard, Vice President for Subsea7 US, said: “We have been working closely with bp and...